Topical steroid preparations. the relationship between the clinical use and the formulation of the product base
Hirst, C.
Australian Family Physician 9(11): 816-819
1980
ISSN/ISBN: 0300-8495 PMID: 7213215 Document Number: 155738
Document emailed within 1 workday
Related Documents
Lundell, E. 1975: A double blind trial of a new topical steroid formulation containing desoximetasone against fluocinolonacetonid cream Zeitschrift für Hautkrankheiten Suppl 2: 17-19Herndon, J.H. 1981: Use and abuse of topical steroid preparations Texas Medicine 77(3): 34-35
Del Rosso, J.Q.; Kircik, L.H. 2014: Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 13(7): S77-S83
Piechota-Urbańska, M. 2010: The effect of dry standardized plant extracts on the process of arbutin release from topical preparations produced on Carbopol base Polimery W Medycynie 40(1): 65-71
Gul, R.; Jan, S.U.; Ahmed, M.; Faridullah, S.; Akhtar, M. 2019: Extraction, formulation and characterization of an in vitro and ex-vivo evaluation of Thymus serpyllum L. (Thymus oil) from topical preparations using dialysis cellulose membrane and natural rabbit skin Pakistan Journal of Pharmaceutical Sciences 32(4): 1563-1570
Harper, J.C. 2010: Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations Journal of Drugs in Dermatology: Jdd 9(5): 482-487
Makino, E.T.; Jiang, L.I.; Tan, P.; Cheng, T.; Mehta, R.C. 2018: Addressing Male Facial Skin Concerns: Clinical Efficacy of a Topical Skincare Treatment Product for Men Journal of Drugs in Dermatology: Jdd 17(3): 301-306
Stocchi, F. 1977: Clinical tests of topical preparations containing betamethasone 17-benzoate and the same associated with 5,7-dichloro-8-hydroxyquinoline (chloroxine) La Clinica Terapeutica 83(4): 359-369
A.Zoom, A.A. 2002: Using cointegrated equations to study long run relationship between agricultural product and gross domestic product in Saudi Arabia Dirasat Agricultural Sciences 29(2): Ar153-Ar166
Scheidel, B.; Blume, H.; Walter, K.; von Nieciecki, A.; Babej-Dölle, R.M. 1993: Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation Arzneimittel-Forschung 43(11): 1211-1215
Gola, M.; Milanesi, N.; D'Erme, A.M. 2014: Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(4): 435-439
Del Rosso, J.Q.; Kircik, L.H. 2013: The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 12(2): S5
Mollica, J.A.; Lin, K.S. 1971: Parenteral formulation V: development of analytical methods for a sterile product Bulletin of the Parenteral Drug Association 25(3): 140-148
Kim, S.Tae.; Jang, D-Jin.; Kim, J.Hyo.; Park, J.Yeon.; Lim, J.Soo.; Lee, S.Yeon.; Lee, K-Mi.; Lim, S-Jeong.; Kim, C-Kook. 2009: Topical administration of cyclosporin A in a solid lipid nanoparticle formulation Die Pharmazie 64(8): 510-514
Kolár, J.; Svejdová, J. 2005: Prescription and structure of formulation of medicinal preparations in a pharmacy. Ii Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 54(1): 29-33
Ewing, L.L.; Cochran, R.C.; Adams, R.J.; Darney, K.J.; Berry, S.J.; Bordy, M.J.; Desjardins, C. 1983: Testis function in rhesus monkeys treated with a contraceptive steroid formulation Contraception 27(4): 347-362
Ayanoglu, G.; Witte, P.U.; Badian, M. 1983: Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil) International Journal of Clinical Pharmacology Therapy and Toxicology 21(9): 479-482
Le Gall, F.; Levèque, J.L.; Poelman, M.C. 1985: Determination of the effect of formulation on the bioavailability of topical corticoids by non-contact reflectometry Pharmaceutica Acta Helvetiae 60(4): 125-128
Mehta, R.C.; Smith, S.R.; Grove, G.L.; Ford, R.O.; Canfield, W.; Donofrio, L.M.; Flynn, T.C.; Leyden, J.J. 2008: Reduction in facial photodamage by a topical growth factor product Journal of Drugs in Dermatology: Jdd 7(9): 864-871
Gul, R.; Jan, S.U.; Ahmed, M.; Akhtar, M.; Qureshi, M.M. 2019: Formulation, characterization and in vivo evaluation of Hedera helix L., topical dosage forms Pakistan Journal of Pharmaceutical Sciences 32(6): 2605-2610